SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-021355
Filing Date
2021-04-28
Accepted
2021-04-28 16:14:25
Documents
5
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A crsp-def14a_20210610.htm DEF 14A 2361361
2 GRAPHIC gngji1r5lnzb000002.jpg GRAPHIC 23968
3 GRAPHIC gngji1r5lnzb000003.jpg GRAPHIC 129565
4 GRAPHIC gngji1r5lnzb000001.jpg GRAPHIC 19505
5 GRAPHIC gngji1r5lnzb000004.jpg GRAPHIC 114026
  Complete submission text file 0001564590-21-021355.txt   2758305
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37923 | Film No.: 21864390
SIC: 2836 Biological Products, (No Diagnostic Substances)